Living Longer: Stage 4 Stomach Cancer (2nd line treatments)

Upon failure of first line treatment for advanced/ stage 4 stomach cancer, patients with good performance status will benefit from second line treatments. Which agent(s), chemotherapy/ biologic or immunotherapy offer longest median OS in this setting? Second-line Treatments Docetaxel: median OS of 5.2 months (COUGAR-02) – 8.4 months (Lee, 2005) Paclitaxel: median OS of 7.8…… Continue reading Living Longer: Stage 4 Stomach Cancer (2nd line treatments)

Living Longer: Stage 4 Stomach Cancer (1st line treatments)

In Malaysia, stomach cancer is the 8th most common cancer. Most stomach cancers were detected at late stage; III (25%) and IV (50%). The average/ median overall survival for stage 4 stomach cancer is not high but there had been incremental increases in average/ median overall survival throughout the years with chemotherapy and lately, with…… Continue reading Living Longer: Stage 4 Stomach Cancer (1st line treatments)